The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
Z. Allibhai,M. Taremi,4 Authors,B. Cho
2013 · DOI: 10.1016/j.ijrobp.2013.08.020
International Journal of Radiation Oncology, Biology, Physics · 156 Citations
TLDR
Current employed stereotactic body radiation therapy dose regimens can provide safe effective local therapy even for larger solitary NSCLC tumors but are associated with more nonlocal failures as well as poorer survival.